The successful clinical application of adenovirus ( Ad ) in cancer control has been of limited success because of the current inability to infect the majority of cancer cells with a large amount of vector. In this study, we show that when human lung tumors growing in immunodeficient nude mice were coinfected with a replication -defective ( RD ) Ad vector expressing green fluorescent protein and a replication -competent ( RC ) Ad vector named KD3, KD3 enhanced the expression of green fluorescent protein throughout the tumor. Also, KD3 and another RC vector named KD1 complemented the expression of luciferase from a RD vector in a human liver tumor xenotransplant in nude mice. Altogether, these results suggest that the combination of a RD vector with a RC vector might be a more effective treatment for cancer than either vector alone due to more widespread dissemination of the virus.
H uman adenovirus serotype 5 ( Ad5 ) offers great promise in cancer gene therapy. It is benign, primarily causing asymptomatic or mild respiratory infections in young children, followed by long -term effective immunity. 1 Fatalities are extremely rare. It transduces genes with high efficacy.
There are two general types of Ad5 -based vectors, replication-defective (RD ) and replication -competent (RC). 2, 3 RD vectors lack the Ad E1A, E1B, and E3 transcription units. The E1A proteins deregulate the cell cycle so that Ad DNA can replicate efficiently, and they also induce transcription of other Ad genes. 4 The deleted E1A and E1B regions (known collectively as E1 ) are usually replaced by an expression cassette where a therapeutic gene, e.g., p53, is expressed from a foreign promoter, e.g., the human cytomegalovirus ( CMV ) immediate early promoter. Vectors that lack E1A are defective for replication because Ad genes are not transcribed. The E1B proteins function to inhibit apoptosis, and are not absolutely required for replication. 4, 5 The E3 proteins protect infected cells from attack by the immune system, and they, too, are not essential for replication. 4, 6 RC vectors destroy cells as part of the virus life cycle. The Ad mutant dl1520, 7 which has been named ONYX -015 by ONYX Pharmaceuticals (Richmond, CA) has been used as an RC vector. 8 -10 This virus has a deletion in the Ad5 E1B region that removes the gene for a protein named E1B -55K. 7 The E1B -55K protein binds p53, 11, 12 blocks transcription from p53-responsive promoters, 13, 14 and inhibits p53-induced apoptosis and allows the cell cycle to be deregulated.
5 E1B -55K can also interact with the Ad protein named E4ORF6 coded by the Ad E4 transcription unit to induce degradation of p53. 15 -17 E1B -55K and E4ORF6 also act together to facilitate transport of Ad mRNA from the nucleus. 18 Because of these many functions of E1B -55K, complete deletion mutants of E1B -55K ( such as dl1520 ) are somewhat defective for replication in many cancer and primary cell types. 9,19 -21 Two other RC vectors that have undergone preclinical studies are named KD1 and KD3.
22 KD1 and KD3 have two mutations ( the same mutations ) in the E1A region that allow the vectors to replicate in cancer cells but not normal cells, and they are highly lytic because they overexpress a protein ( the Adenovirus Death Protein, ADP ) that mediates lysis of cells and the release of Ad from cells. There are other RC vectors that have expression of the E1A gene under control of the tissue -and /or cancer-specific promoters for prostatespecific antigen 23 -25 and -fetoprotein. 26 This communication presents a novel approach to increase the efficacy of cancer gene therapy. We show here that the RC vector KD3 complements the expression of green fluorescent protein ( GFP ) from the Ad -GFP RD vector in a human lung tumor xenotransplant growing in immunodeficient nude mice, and that both KD1 and KD3 complement the expression of luciferase from an Ad -Luc RD vector in a human liver tumor xenotransplant in nude mice.
Materials and methods

Cell culture
A549 cells, a human alveolar adenocarcinoma cell line obtained from ATCC (Manassas, VA) were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco/ BRL, Life Technologies, Paisley, Scotland ) with 10% FBS.
Viruses
The Ad vectors KD1 and KD3 have been described elsewhere. 22 Both are RC vectors with the same two small deletions of the E1A gene. These deletions preclude binding of the E1A proteins to pRB or p300 /CBP, 27 but leave intact the ability of the E1A proteins to transactivate Ad transcription units. KD1 and KD3 also overexpress the ADP, a protein required for efficient lysis of cells, release of Ad from cells, and infection of other cells. 22, 28, 29 KD1 and KD3 replicate well in most cancer cell lines, but not in primary or quiescent cells. 22 All E3 genes are deleted in KD1 ( except the adp gene ), and all E3 genes except the E3 -12.5K and adp genes are deleted in KD3. 22 
Ad -GFP is an E1G
: E3G : RD Ad vector expressing GFP from the RSV-LTR promoter inserted into the deleted E1 region. Ad -GFP was obtained from Ratna Ray (St. Louis University ). Ad -Luc is an E1G : E3G : RD Ad vector expressing luciferase from the CMV promoter. Ad -Luc was obtained from Jeffrey Whitsett (University of Cincinnati ).
Coinfection of tumors in nude mice
In the A549 xenograft experiment with Ad -GFP, 1Â10 7 A549 cells were injected subcutaneously into each hind flank of 4 -to 6-week -old female nude mice and allowed to grow into tumors, as described previously. 22 Tumors of about 400 mL, as determined by the formula lengthÂwidth 2/ 2, were injected with the vector in 30 mL of DMEM. Both tumors on one mouse were injected with 2Â10 7 fluorescence units ( about 10 8 pfu ) of Ad -GFP alone, or 2Â10 7 fluorescence units of Ad -GFP plus 2Â10 8 pfu of KD3. After 8 days, the mice were euthanised, then the tumors ( about 1-3 cm in diameter ) were removed, placed in PBS, immediately cut into, ca., 1 -mm slices, and immediately examined for fluorescence under UV light.
In the Hep3B xenograft experiment with Ad -Luc, Hep3B cells were injected into the hind flanks of nude mice and tumors allowed to form. 22 Tumors of about 500 mL were injected with 1Â10 7 pfu of Ad -Luc, 1Â10 7 pfu of Ad -Luc plus 5Â10 7 of KD1, or 1Â10 7 pfu of Ad -Luc plus 5Â10 7 pfu of KD3. After 2 weeks, tumors were collected, homogenized, and luciferase activity was determined.
Results
The increased cytotoxic effect of dl1520 and Ad -p53 is likely due, at least in part, to complementation by dl1520 of Ad -p53. That is, the E1A proteins synthesized from the dl1520 genome will induce transcription of Ad genes from both dl1520 and Ad -p53. Both genomes will replicate, and in the case of Ad -p53, there will be more templates for transcription of the p53 gene. At low MOIs, dl1520 should complement the replication and spread of Ad -p53 to other cells. This latter conclusion would be consistent with the earlier observations that when cells are coinfected with KD3 and an E1G : RD vector ( Ad /gal ) expressing À galactosidase ( À gal ) as a transgene, KD3 will dramatically increase the amount of À gal produced as well as the spread of the Ad /gal vector throughout cell monolayers. 22 To address whether the RC vectors KD3 and KD1 will complement transgene expression from an E1G : E3G : RD vector and complement the spread of the RD vector throughout a tumor, the following experiment was conducted using Ad -Luc, an E1G : E3G : RD vector expressing luciferase as a transgene. Hep3B human liver tumor xenografts of $0.5 mL growing in immunodeficient nude mice were injected with 1Â10 7 pfu of the Ad -Luc RD vector alone, with 1Â10 7 pfu of Ad -Luc plus 5Â10 7 pfu of KD3, or 1Â10 7 pfu of Ad -Luc plus 5Â10 7 pfu of the KD1 RC vector. After 2 weeks, the tumors were harvested, proteins were extracted, and luciferase activity was determined. The combination of KD3 plus Ad -Luc yielded 22 -fold more luciferase activity than Ad -Luc alone, and KD1 plus AdLuc yielded 17 -fold more activity ( Fig 1) . These results show that KD3 and KD1 complement the expression of luciferase by Ad -Luc in liver tumors xenografts.
To obtain evidence that a RC vector will complement not only transgene expression but also intratumor spread, another experiment was conducted, this time using KD3 and Ad -GFP, an E1G : E3G : RD vector expressing GFP. A549 tumors of about 400 mL in nude mice were injected with 2Â10 7 fluorescence units of Ad -GFP (alone ), or with 2Â10 7 fluorescence units of Ad -GFP plus 2Â10 8 pfu of KD3. Figure 2 shows the fluorescence in 1-mm tumor slices after 8 days. With Ad -GFP alone, there was localized fluorescence in the tumor (the image shown is only the edge of the tumor; much of the nonfluorescent portion of the tumor cannot be seen ). In stark contrast, with the combination of Ad -GFP and KD3, nearly all the tumors showed bright fluorescence (Fig 2) . This result shows, at a minimum, that KD3 greatly increases the amount of GFP in the tumor. Because the fluorescence is seen throughout the tumor rather than a localized area, most likely, KD3 has complemented the spread of Ad -GFP throughout the tumor.
Discussion
In previous studies when KD3 and the E1G : E3G : Ad /gal vector were coinfected into cultured A549 cells at 10 pfu / cell, KD3 caused a 1000-fold increase in titers of Ad /gal. 22 In an infectious center assay where single cells were doubly infected with both KD3 and Ad / gal, KD3 also caused the spread from cell to cell of Ad / gal. 22 Here we have shown that KD1 and KD3 complement luciferase expression from the E1G : E3G : RD Ad -Luc vector in liver tumor xenografts in nude mice. A $20 -fold increase in luciferase was obtained after 2 weeks. We have also shown that KD3 complements expression of GFP from the E1G : E3G : Ad -GFP vector in A549 tumor xenografts growing in nude mice. This increase in GFP almost certainly occurred because KD3 and Ad -GFP coinfected some cells in the tumor and KD3 complemented DNA replication of Ad -GFP, resulting in more templates of the Ad -GFP from which the GFP gene could be transcribed. Although not formally proven, expression of ADP in these cells very likely caused cell lysis, allowing KD3 and Ad -GFP to coinfect other cells and go through the process of coreplication and gene expression. The 8 days of the experiment should allow for several rounds of coreplication. It should be noted that coinfection is not necessary for GFP to be expressed. For example, some of the fluorescent cells in Figure 2 could be coinfected, and some could be infected with Ad -GFP only; GFP would be expressed in either case.
We anticipate that if KD3 ( or dl1520 ) was used to coinfect tumors with an E1G RD Ad vector expressing an anticancer protein, e.g., p53, there would be more tumor destruction than with KD3 alone or the RD vector alone. 22 Indeed, while this work was in progress, a report that is consistent with this idea appeared. Coinfection of a RC Ad with a RD Ad carrying an IL -2 or an interleukin 12 (IL -12) gene was shown to support in trans the replication of the RD virus. 30 Consequently, the production of IL -2 and IL -12 was potentiated more than a 100 -fold. Moreover, the coinfection significantly increased the in vivo antitumor efficacy of both viruses. 30 In another study, coinfection of cultured glioma cells with two RD vectors, one expressing p53 and the other Fas ligand, caused greater cell destruction than either vector by itself. 31 In summary, we show that the combination of the Ad -GFP RD vector with the KD3 RC vector results in much greater GFP expression in xenotransplants than the Ad -GFP vector alone. It is very likely that the combination will result in higher expression of transgene in tumors, and that the tumor cells will be killed by both transgene function and Ad replication. Therefore, this study describes a new therapeutic approach to cancer treatment, based on the simultaneous use of two viruses for the treatment of cancer. 
